Atai Life Sciences N.V. (ATAI)
NASDAQ: ATAI · Real-Time Price · USD
5.28
-0.07 (-1.31%)
At close: Nov 4, 2025, 4:00 PM EST
5.27
-0.01 (-0.19%)
Pre-market: Nov 5, 2025, 4:21 AM EST
Atai Life Sciences Market Cap
Atai Life Sciences has a market cap or net worth of $1.13 billion as of November 5, 2025. Its market cap has increased by 462.03% in one year.
Market Cap
1.13B
Enterprise Value
1.05B
1-Year Change
462.03%
Ranking
Category
Stock Price
$5.28
Market Cap Chart
Since the IPO on June 18, 2021, Atai Life Sciences's market cap has decreased from $2.29B to $1.13B, a decrease of -50.55%. That is a compound annual growth rate of -14.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 1.15B | 413.81% |
| Dec 31, 2024 | 223.18M | -4.66% |
| Dec 29, 2023 | 234.07M | -46.95% |
| Dec 30, 2022 | 441.23M | -63.92% |
| Dec 31, 2021 | 1.22B | -46.56% |
| Jun 18, 2021 | 2.29B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 802.74B |
| Johnson & Johnson | 448.76B |
| AbbVie | 374.44B |
| UnitedHealth Group | 302.36B |
| AstraZeneca | 252.04B |
| Novartis AG | 236.44B |
| Novo Nordisk | 216.34B |
| Abbott Laboratories | 215.34B |